In CNS clinical trials, using accurate CNS clinical trial rating scales is essential for assessing outcomes effectively.

DASH Neuroscience Announcement

Important Update! As of today, our website at Harm Research will become DASH Neuroscience. It is now even easier to license my interviews and scales directly from me, the author and Copyright Holder of the MINI International Neuropsychiatric Interview (MINI), MINI-Kid, SDS, S-STS and S-HTS on my website. It’s also easier to find information on and sign up for my trusted Training platform. We hope you like our new name. We think it captures the spirit of what we do. DASH — a nod to the simplicity and brevity of Dr. David Sheehan’s neuropsychiatric instruments, while combining the first two letters of his first and last names (DAvid SHeehan) and honoring his late son, Dashiell Devere Sheehan—is dedicated to advancing mental health innovation through Dr. Sheehan’s licensing, training and consultation by continuing Dr. Sheehan’s four-decade legacy of creating and providing gold-standard diagnostic tools and CNS clinical trial rating scales that are essential, now translated into 80+ languages, for use in research and clinical trials and studies. At DASH, we are as focused as ever on helping you with your licensing, training and consultation needs. Our commitment to CNS rating scales in clinical trials ensures high-quality results in your studies. 

Meet our Team:

    • David V. Sheehan: Founder | Copyright/Trademark Holder of the MINI, MINI Kid, SDS, S-STS, S-HTS and more.

    • Tara Sheehan: CEO | Driving innovation and global connections.

    • Jennifer Giddens: Managing Director of Training and Co-Founder of the Harm Research Institute | the Academic and Training arm of DASH

Licensing Matters: Only direct licensees receive Dr. Sheehan’s consultation, training, and regulatory guidance in CNS clinical trials. Make sure your MINI and Sheehan scales have a QR code linking to DASH Neuroscience/Harm Research Institute to know it came from the Copyright Holder. Our focus on CNS clinical trial rating scales helps maintain quality across research initiatives.